A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Description

This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments for these conditions target the central nervous system, these children are at increased risk for developing neurocognitive late effects (problems with attention, thinking, learning, and remembering). Fortunately, many survivors do well, but some children continue to struggle with learning and have academic difficulties after their cancer treatments. The purpose of this research study is to see whether providing parents with educational knowledge and parenting tips using videoconferencing and a special website better helps their cancer survivor child in learning and school achievement compared to typical services.

Conditions

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoblastic Lymphoma

Study Overview

Study Details

Study overview

This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments for these conditions target the central nervous system, these children are at increased risk for developing neurocognitive late effects (problems with attention, thinking, learning, and remembering). Fortunately, many survivors do well, but some children continue to struggle with learning and have academic difficulties after their cancer treatments. The purpose of this research study is to see whether providing parents with educational knowledge and parenting tips using videoconferencing and a special website better helps their cancer survivor child in learning and school achievement compared to typical services.

Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children With Cancer

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Condition
Acute Leukemia
Intervention / Treatment

-

Contacts and Locations

Duarte

City of Hope Medical Center, Duarte, California, United States, 91010

Los Angeles

Childrens Hospital of Los Angeles, Los Angeles, California, United States, 90027

San Diego

Rady Children's Hospital San Diego, San Diego, California, United States, 92123

San Francisco

University of Calif San Francisco, San Francisco, California, United States, 94115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Documented informed consent of the participant and/or legally authorized representative
  • * Assent, when appropriate, will be obtained per institutional guidelines
  • * Primary participating parent/caregiver is English- or Spanish-speaking (any race/ethnicity)
  • * Child is aged 6-12 years (yr.) (for the website usability pre-study, child is age 8 - 12 yrs.)
  • * Child understands English (but can be bilingual)
  • * Child treated for acute leukemia (e.g., acute lymphoblastic leukemia, acute myelogenous leukemia) or lymphoblastic lymphoma
  • * Child is in cancer remission and has completed cancer therapies, including maintenance treatment
  • * Primary participating parent/caregiver has daily contact with the child
  • * Child is enrolled in school
  • * Recent or current participation in a behavioral intervention study with a similar focus
  • * History of major psychiatric condition (e.g., psychosis) in parent or child
  • * Severe neurodevelopmental disorder in the child (e.g., down syndrome, intellectual disability)
  • * Child has previously used the IXL online learning program extensively and unwilling to regularly use it again
  • * Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns with clinical study procedures
  • * Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)

Ages Eligible for Study

6 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

City of Hope Medical Center,

Sunita K Patel, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

2027-06-30